11,764 reports of this reaction
5.0% of all BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE reports
#2 most reported adverse reaction
ASTHMA is the #2 most commonly reported adverse reaction for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 11,764 FDA adverse event reports linking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE to ASTHMA. This represents approximately 5.0% of all 236,943 adverse event reports for this drug.
Patients taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE who experience asthma should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHMA is moderately reported among BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE users, representing a notable but not dominant share of adverse events.
In addition to asthma, the following adverse reactions have been reported for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE:
The following drugs have also been linked to asthma in FDA adverse event reports:
ASTHMA has been reported as an adverse event in 11,764 FDA reports for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHMA accounts for approximately 5.0% of all adverse event reports for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, making it one of the most commonly reported side effect.
If you experience asthma while taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.